ARTICLE | Company News
D-Pharm, Lilly in CNS deal
March 1, 2001 8:00 AM UTC
D-Pharm (Rehovot, Israel) will use its lipid vector technology to link specific lipids to certain of LLY's CNS compounds to create prodrugs. LLY will provide preclinical testing of the compounds, and ...